143 related articles for article (PubMed ID: 22292621)
1. Codon 72 and G13964C intron 6 polymorphisms of TP53 in relation to development and progression of breast cancer in India.
Surekha D; Sailaja K; Rao DN; Padma T; Raghunadharao D; Vishnupriya S
Asian Pac J Cancer Prev; 2011; 12(8):1893-8. PubMed ID: 22292621
[TBL] [Abstract][Full Text] [Related]
2. TP53 polymorphisms in gliomas from Indian patients: Study of codon 72 genotype, rs1642785, rs1800370 and 16 base pair insertion in intron-3.
Jha P; Jha P; Pathak P; Chosdol K; Suri V; Sharma MC; Kumar G; Singh M; Mahapatra AK; Sarkar C
Exp Mol Pathol; 2011 Apr; 90(2):167-72. PubMed ID: 21115003
[TBL] [Abstract][Full Text] [Related]
3. Analysis of polymorphisms in codons 11, 72 and 248 of TP53 in Brazilian women with breast cancer.
Almeida BC; Kleine JP; Camargo-Kosugi CM; Lisboa MR; França CN; França JP; Silva ID
Genet Mol Res; 2016 Feb; 15(1):. PubMed ID: 26909997
[TBL] [Abstract][Full Text] [Related]
4. No association of TP53 codon 72 and intron 3 16-bp duplication polymorphisms with breast cancer risk in Chinese Han women: new evidence from a population-based case-control investigation.
Hao W; Xu X; Shi H; Zhang C; Chen X
Eur J Med Res; 2018 Oct; 23(1):47. PubMed ID: 30309383
[TBL] [Abstract][Full Text] [Related]
5. The TP53 intron 6 G13964C polymorphism and risk of thyroid and breast cancer development in the Iranian Azeri population.
Dehghan R; Hosseinpour Feizi MA; Pouladi N; Adampourezare M; Farajzadeh D
Asian Pac J Cancer Prev; 2015; 16(7):3073-7. PubMed ID: 25854408
[TBL] [Abstract][Full Text] [Related]
6. P53 codon 72 and HER2 codon 655 polymorphisms in Turkish breast cancer patients.
Kara N; Karakus N; Ulusoy AN; Ozaslan C; Gungor B; Bagci H
DNA Cell Biol; 2010 Jul; 29(7):387-92. PubMed ID: 20380571
[TBL] [Abstract][Full Text] [Related]
7. p53 codon 72 polymorphism as a risk factor in the development of breast cancer.
Papadakis EN; Dokianakis DN; Spandidos DA
Mol Cell Biol Res Commun; 2000 Jun; 3(6):389-92. PubMed ID: 11032762
[TBL] [Abstract][Full Text] [Related]
8. Breast cancer risk in relation to TP53 codon 72 and CDH1 gene polymorphisms in the Bangladeshi women.
Shabnaz S; Ahmed MU; Islam MS; Islam MR; Al-Mamun MM; Islam MS; Hasnat A
Tumour Biol; 2016 Jun; 37(6):7229-37. PubMed ID: 26666818
[TBL] [Abstract][Full Text] [Related]
9. Polymorphism of TP53 codon 72 showed no association with breast cancer in Iranian women.
Khadang B; Fattahi MJ; Talei A; Dehaghani AS; Ghaderi A
Cancer Genet Cytogenet; 2007 Feb; 173(1):38-42. PubMed ID: 17284368
[TBL] [Abstract][Full Text] [Related]
10. TP53 codon 72 polymorphism and breast cancer risk in Bangladeshi population.
Hossain A; Murshid GMM; Zilani MNH; Islam F; Sultana R; Sultana T; Hossain MG; Rahman MM
Breast Cancer; 2017 Jul; 24(4):571-578. PubMed ID: 27837441
[TBL] [Abstract][Full Text] [Related]
11. Arginine homozygosity in codon 72 of p53 correlates with failure to imatinib response in chronic myeloid leukemia.
Camelo-Santos J; do Prado Barbosa A; de Paula Silveira-Lacerda E; Guillo LA
Biomed Pharmacother; 2013 Mar; 67(2):103-7. PubMed ID: 23433851
[TBL] [Abstract][Full Text] [Related]
12. P53 codon 72 polymorphism in breast cancer.
Buyru N; Tigli H; Dalay N
Oncol Rep; 2003; 10(3):711-4. PubMed ID: 12684648
[TBL] [Abstract][Full Text] [Related]
13. p53 exon 4 (codon 72) polymorphism and exon 7 (codon 249) mutation in breast cancer patients in southern region (Madurai) of Tamil Nadu.
Vijayaraman KP; Veluchamy M; Murugesan P; Shanmugiah KP; Kasi PD
Asian Pac J Cancer Prev; 2012; 13(2):511-6. PubMed ID: 22524816
[TBL] [Abstract][Full Text] [Related]
14. Lack of association of intron 3 16 bp polymorphism of TP53 with breast cancer among Iranian-Azeri patients.
Pouladi N; Kouhsari SM; Feizi MH; Dehghan R; Azarfam P; Farajzadeh D
Asian Pac J Cancer Prev; 2014; 15(6):2631-4. PubMed ID: 24761875
[TBL] [Abstract][Full Text] [Related]
15. The TP53 codon 72 polymorphism and predisposition to adrenocortical cancer in Polish patients.
Ignaszak-Szczepaniak M; Horst-Sikorska W; Sawicka J; Kaczmarek M; Slomski R
Oncol Rep; 2006 Jul; 16(1):65-71. PubMed ID: 16786124
[TBL] [Abstract][Full Text] [Related]
16. A study on the association of cytochrome-P450 1A1 polymorphism and breast cancer risk in north Indian women.
Singh V; Rastogi N; Sinha A; Kumar A; Mathur N; Singh MP
Breast Cancer Res Treat; 2007 Jan; 101(1):73-81. PubMed ID: 16807674
[TBL] [Abstract][Full Text] [Related]
17. Association of p53 and p21(CDKN1A/WAF1/CIP1) polymorphisms with oral cancer in Taiwan patients.
Bau DT; Tsai MH; Lo YL; Hsu CM; Tsai Y; Lee CC; Tsai FJ
Anticancer Res; 2007; 27(3B):1559-64. PubMed ID: 17595776
[TBL] [Abstract][Full Text] [Related]
18. Implication of BRCA2 -26G>A 5' untranslated region polymorphism in susceptibility to sporadic breast cancer and its modulation by p53 codon 72 Arg>Pro polymorphism.
Gochhait S; Bukhari SI; Bairwa N; Vadhera S; Darvishi K; Raish M; Gupta P; Husain SA; Bamezai RN
Breast Cancer Res; 2007; 9(5):R71. PubMed ID: 17945002
[TBL] [Abstract][Full Text] [Related]
19. Lack of evidence that proline homozygosity at codon 72 of p53 and rare arginine allele at codon 31 of p21, jointly mediate cervical cancer susceptibility among Indian women.
Bhattacharya P; Sengupta S
Gynecol Oncol; 2005 Oct; 99(1):176-82. PubMed ID: 16054204
[TBL] [Abstract][Full Text] [Related]
20. Frequency of TP53 mutations in relation to Arg72Pro genotypes in non small cell lung cancer.
Lind H; Ekstrøm PO; Ryberg D; Skaug V; Andreassen T; Stangeland L; Haugen A; Zienolddiny S
Cancer Epidemiol Biomarkers Prev; 2007 Oct; 16(10):2077-81. PubMed ID: 17932356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
